Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus

Tissue Antigens

Volumn 65, Issue 2, 2005, Pages 183-186

  Orozco, G ^a   Sanchez E ^a   Collado, M D ^a   Lopez Nevot M A ^b   Paco, L ^b   Garcia A ^b   Jimenez Alonso J ^b   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

94ins delATTG polymorphism; CA microsatellite polymorphism; Genetics; Nuclear factor B; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICROSATELLITE DNA;

ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NFKB1 GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

EID: 14844320149     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00341.x     Document Type: Article

References (21)

1. Ghosh S, Karin M. Missing pieces in the NF-κB puzzle. Cell 2002: 109: 81-96.
2. Quitang L, Verma IM. NF-kB regulation in the immune system. Nat Rev Immunol 2002: 2: 725-34.
3. Miagkov A, Kovalenko D, Brown CE et al. NFkB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 1998: 95: 13859-64.
4. Muller-Ladner U, Gay RE, Gay S. Role of nuclear factor kappa in synovial inflammation. Curr Rheumatol Rep 2002: 4: 201-7.
5. Makarov SS. NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia and tissue destruction. Arthritis Res 2001: 3: 200-6.
6. Collantes E, Blázquez M, Mazorra V, Macho A, Aranda E, Muñoz E. Nuclear factor-κB activity in cells from patients with rheumatic diseases: a preliminary report. Ann Rheum Dis 1998: 57: 738-41.
7. Wong HK, Kammer GM, Dennis G, Tsokos GC. Abnormal NF-kB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol 1999: 163: 1682-9.
8. Tsokos GC, Wong HK, Enyedy EJ, Nambiar MP. Immune cell signalling in lupus. Curr Opin Rheumatol 2000: 12: 355-63.
9. Karban AS, Okazaki T, Panhuysen CI et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004: 13: 35-45.
10. Eyre S, Barton A, Shephard N et al. Investigation of susceptibility loci identified in the UK rheumatoid arthritis whole-genome scan in a further series of 217 UK affected sibling pairs. Arthritis Rheum 2004: 50: 729-35.
11. Gaffney PM, Kearns GM, Shark KB et al. A genome wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 1998: 95: 14875-9.
12. Ota N, Nakajima T, Shirai Y, Emi M. Isolation and radiation hybrid mapping of a highly polymorphic CA repeat sequence at the human nuclear factor kappa-beta subunit (NFKB1) locus. J Hum Genet 1999: 44: 129-30.
13. Hegazy DM, O'Reilly DA, Yang BM, Hodgkinson AD, Millward BA, Demaine AG. NFκB polymorphisms and susceptibility to type 1 diabetes. Genes Immun 2001: 2: 304-8.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-24.
15. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification for systemic lupus erythematosus. Arthritis Rheum 1982: 25: 1271-7.
16. Wandstrat A, Wakeland E. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat Immunol 2001: 2: 802-9.
17. Gylvin T, Bergholdt R, Nerup J, Pociot F. Characterization of a nuclear-factor-kappa B (NFkB) genetic marker in type 1 diabetes (T14DM) families. Genes Immun 2002: 3: 430-2.
18. Miterski B, Böerhringer S, Klein W et al. Inhibitors in the NFkB cascade comprise prime candidate genes predisposing to multiple sclerosis, specially in selected combinations. Genes Immun 2002: 3: 211-9.
19. Curran JE, Weinstein SR, Griffiths LR. Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 2002: 188: 103-7.
20. Martinez A, Pascual M, Pascual-Salcedo D, Balsa A, Martín JG, de la Concha E. Genetic polymorphism in Spanish rheumatoid arthritis patients: an association and linkage study. Genes Immun 2003: 4: 117-21.
21. Collado MD, Torres B, Rueda B et al. No evidence of association between IKBL promoter polymorphism and rheumatoid arthritis. Arthritis Rheum 2004: 50: 2032-3.